Brief: Gt Biopharma Adds University Of Wisconsin--Madison Carbone Cancer Center As Second Site In Ongoing Phase 1/2 Clinical Trial Of Gtb-3550 Trike

GT Biopharma

04/03/2021 13:44

March 4 (Reuters) - GT Biopharma Inc  GTBP.O :
    * GT BIOPHARMA ADDS UNIVERSITY OF WISCONSIN--MADISON CARBONE
CANCER CENTER AS SECOND SITE IN ONGOING PHASE 1/2 CLINICAL TRIAL
OF GTB-3550 TRIKE™,  A NOVEL NK CELL THERAPEUTIC CANCER
TREATMENT

Source text for Eikon:  ID:nPn2qZydLa 
Further company coverage:  GTBP.O 

 ((Reuters.Briefs@thomsonreuters.com;))